Stifel Financial Corp cut its stake in shares of CVS Health Corp (NYSE:CVS) by 7.4% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,291,329 shares of the pharmacy operator’s stock after selling 102,626 shares during the period. Stifel Financial Corp owned about 0.13% of CVS Health worth $103,918,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. FMR LLC raised its stake in CVS Health by 22.0% during the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after purchasing an additional 5,446,930 shares during the last quarter. Boston Partners grew its holdings in shares of CVS Health by 69.1% in the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after purchasing an additional 2,638,888 shares during the last quarter. Parametric Portfolio Associates LLC grew its holdings in shares of CVS Health by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after purchasing an additional 1,647,168 shares during the last quarter. Prudential Financial Inc. grew its holdings in shares of CVS Health by 61.8% in the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after purchasing an additional 1,125,400 shares during the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of CVS Health by 8.4% in the 2nd quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after purchasing an additional 1,100,373 shares during the last quarter. 82.24% of the stock is owned by institutional investors.

Shares of CVS Health Corp (NYSE CVS) opened at $73.09 on Friday. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The firm has a market capitalization of $72,013.60, a PE ratio of 12.45, a price-to-earnings-growth ratio of 1.33 and a beta of 0.89. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. During the same period last year, the company earned $1.64 EPS. CVS Health’s revenue for the quarter was up 3.5% compared to the same quarter last year. equities research analysts forecast that CVS Health Corp will post 5.9 earnings per share for the current year.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares in the company, valued at $3,504,758.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Larry J. Merlo sold 241,150 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total value of $20,032,330.50. Following the completion of the transaction, the insider now owns 299,255 shares of the company’s stock, valued at approximately $24,859,112.85. The disclosure for this sale can be found here. Over the last quarter, insiders sold 714,125 shares of company stock worth $58,119,381. Corporate insiders own 0.61% of the company’s stock.

A number of research analysts have issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of CVS Health in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 target price on the stock. Jefferies Group lifted their price objective on shares of CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a research report on Friday, September 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health in a research report on Sunday, September 10th. Wolfe Research downgraded CVS Health from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $89.00 to $82.00 in a report on Monday, August 14th. Finally, Robert W. Baird reaffirmed an “outperform” rating and issued a $90.00 price target on shares of CVS Health in a research note on Monday, August 14th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $86.35.

ILLEGAL ACTIVITY NOTICE: “Stifel Financial Corp Has $103.92 Million Stake in CVS Health Corp (CVS)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/stifel-financial-corp-has-103-92-million-stake-in-cvs-health-corp-cvs/1753780.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.